Pfizer grows 2% as strategic review continues

2 August 2018 - Deborah Wilkes

Worldwide sales at Pfizer's Consumer Healthcare business increased by 2% on an operational basis to USD886 million in the second quarter of 2018. Pfizer continues to evaluate strategic alternatives for its Consumer Healthcare business including spin-offs and joint ventures.